The Challenge of Paediatric Research

Home / Media / Events / The Challenge of Paediatric Research

13th March: The Challenge of Paediatric Research

Speakers

Viviana Giannuzi

PharmD, PhD in cellular biochemistry and pharmacology, and a master’s in clinical research of medicines, she currently coordinates the Research & Innovation Department at Fondazione per la Ricerca Farmacologica Gianni Benzi. She leads ethics and regulatory activities in various international and national research projects. She is a member of the Paediatric Committee at the European Medicines Agency (EMA) as a delegate for patient organizations. Her expertise includes ethics and regulatory, informed consent, health data processing for research, and R&D for rare and paediatric diseases.   

 

 

 

 

Timothy Chou

Dr. Chou began his career at Tandem Computers and later served as the first President of Oracle’s cloud computing business. He is a board member for several public and private companies and has invested in pre-public companies. Currently, he chairs the Alchemist Accelerator, focusing on B2B startups. Inspired by a student, he came out of retirement to launch BevelCloud, aiming to reduce healthcare inequity, lower costs, and improve outcomes for children globally. BevelCloud is building a privacy-preserving, real-time AI cloud infrastructure using data from healthcare machines in children’s hospitals worldwide.

Riccardo Masetti

Prof. Riccardo Masetti is a clinical and translational researcher in pediatric acute leukemias, focusing on myelodysplastic syndromes and the development of novel treatments for myeloproliferative diseases in children. He has contributed to genomic profiling of high-risk childhood leukemia subgroups and is involved in international boards, including the European Working Group of Myelodysplastic Syndromes in Childhood. Affiliated with the European Bone Marrow Transplantation Society (EBMT), his research also explores Hematopoietic Stem Cell Transplantation (HSCT) and the role of gut microbiome characterization and fecal microbiome transplantation in pediatric oncology and hematology.  

 

 

Marek Migdal

Marek Migdał, MD, PhD, graduated from the Medical University of Warsaw in 1979. He has been employed at the Children’s Memorial Health Institute (CMHI) since then, initially in the Department of Paediatrics and later in the Department of Anaesthesiology and Intensive Care. In 2018, he became the Director of CMHI. He completed research internships in France in 1985-1986 and 1990. He specialized in paediatrics and lung diseases, defending his doctoral dissertation in 1990 on lung function measurement in newborns with respiratory failure. He has authored over 230 publications and lectures on paediatric intensive care. He has coordinated several international research grants, including EU-CHS, GRIP, SMART, ID-EPTRI, and c4c.